Skip to main content

Welcome to HAEMExpert!

HAEMExpert is designed for healthcare professionals with an interest in rare bleeding disorders.


home

home

home

Translating FIX real-world European experiences into practice: How can haemophilia B patient outcomes be improved? Part 1

Thursday 5 September, 17:45–19:00 CET

An exciting new webinar featuring Cedric Hermans (Belgium), David Lillicrap (Canada), Annie Harroche (France) and Isabel Rivas (Spain). Join us in September to discuss real-world experiences of FIX use across Europe.

Register here

 


Haemophilia B Gene Therapy: Spotlight on the Liver

Tuesday 24 September, 17:15–18:30 CET

Please join Andreas Tiede (Germany), Heiner Wedemeyer (Germany), Graham Foster (UK), Priyanka Raheja (UK), and Gary Saunders (UK) to discuss the importance of liver health for haemophilia care.

Register here

 


Translating FIX real-world European experiences into practice: How can haemophilia B patient outcomes be improved? Part 2

Tuesday 15 October: 17:00–18:15 CET

Our second webinar in the real-world experiences of FIX in Europe series. Featuring Cedric Hermans (Belgium), David Lillicrap (Canada), Giancarlo Castaman (Italy), Johannes Oldenburg (Germany) and Sarah Mangles (United Kingdom). Join us in the second instalment of this discussion of factor IX use in Europe and listen to our faculty share experiences from patient cases and non-interventional studies.

Register here

 


On-demand webinars and congress symposia are available in the relevant tabs.


Science Updates

Sign up
Article |

LIKE WHAT YOU READ?

Sign up for quarterly highlights straight to your inbox
Navigating FVIII Replacement Pharmacokinetics in Haemophilia A
Article |

NAVIGATING FVIII REPLACEMENT PHARMACOKINETICS IN HAEMOPHILIA A

Learn about the challenges with FVIII product classification and listen to Mariasanta Napolitano as she explores the relevance of pharmacokinetic parameters in haemophilia A.
Gene Therapy and Quality of Life: Findings from the HOPE-B Clinical Trial
Article |

GENE THERAPY AND QUALITY OF LIFE: FINDINGS FROM THE HOPE-B CLINICAL TRIAL

Learn about the impact of etranacogene dezaparvovec on patient-reported outcomes in the HOPE-B trial.